Literature DB >> 7628051

Protein binding modulates inhibition of the epidermal growth factor receptor kinase and DNA synthesis by tyrphostins.

R Hoffman1, I F Dennis, J Donaldson.   

Abstract

Inhibition of growth factor-stimulated DNA synthesis carried out in defined medium is often compared with inhibition of serum-stimulated DNA synthesis so as to assess the selectivity of growth-factor-receptor tyrosine kinase inhibitors such as tyrphostins. We investigated whether protein binding may influence the interpretation of these experiments. Protein binding of tyrphostins was determined by ultrafiltration, equilibrium dialysis or spectrophotometer, and was quantitated by high-performance liquid chromatography (HPLC). For growth factor-stimulated DNA synthesis, we used the non-small-cell lung cancer cell line L23/P stimulated by transforming growth factor alpha (TGF alpha). The epidermal growth factor (EGF)-receptor kinase was assayed by phosphorylation of a peptide substrate or by receptor autophosphorylation. Protein binding of a number of tyrphostins ranged from 64% to 98%. There was a positive correlation (r = 0.995) between the degree of protein binding and the hydrophobicity. Inhibition of the EGF-receptor tyrosine kinase activity by the highly protein-bound tyrphostin B56 [N-(4-phenylbutyl)-3,4-dihydroxybenzylidene cyanoacet-amide] was reduced by bovine serum albumin (BSA), but BSA had less of an effect on inhibition of the EGF-receptor kinase by the weakly protein-bound tyrphostin A47 (RG 50864: 3,4-dihydroxybenzylidene cyanothioacetamide). Tyrphostins B46 [N-(3-phenylpropyl)-3,4-dihydroxybenzylidene cyanoacetamide] and B56 (both highly protein-bound) inhibited DNA synthesis of L23/P cells with approximately 3-fold greater potency in 0.5% serum than in 10% serum, but the inhibition of DNA synthesis in 0.5% serum was reduced by the addition of BSA. Tyrphostins B46 and B56 inhibited DNA synthesis stimulated by TGF alpha in defined medium to a greater extent than DNA synthesis stimulated by serum. However, this apparent selectivity for inhibition of TGF alpha-stimulated DNA synthesis was lost when the protein concentration in the defined medium was made equivalent to that in the serum-containing medium. By contrast, BSA enhanced the selective inhibition of TGF alpha-stimulated DNA synthesis by tyrphostin A47. These results demonstrate that protein binding accounts for the apparent selectivity of some highly protein-bound tyrphostins for TGF alpha-stimulated DNA synthesis of L23/P cells. Therefore, protein binding should be taken into consideration in assessments of the selectivity of tyrphostins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7628051     DOI: 10.1007/BF00689049

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  24 in total

Review 1.  Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers.

Authors:  W J Gullick
Journal:  Br Med Bull       Date:  1991-01       Impact factor: 4.291

2.  Tyrphostins inhibit epidermal growth factor (EGF)-receptor tyrosine kinase activity in living cells and EGF-stimulated cell proliferation.

Authors:  R M Lyall; A Zilberstein; A Gazit; C Gilon; A Levitzki; J Schlessinger
Journal:  J Biol Chem       Date:  1989-08-25       Impact factor: 5.157

3.  An inexpensive small volume equilibrium dialysis system for protein-ligand binding assays.

Authors:  T Reinard; H J Jacobsen
Journal:  Anal Biochem       Date:  1989-01       Impact factor: 3.365

4.  Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC.

Authors:  G A McPherson
Journal:  J Pharmacol Methods       Date:  1985-11

5.  Tyrphostins. 2. Heterocyclic and alpha-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases.

Authors:  A Gazit; N Osherov; I Posner; P Yaish; E Poradosu; C Gilon; A Levitzki
Journal:  J Med Chem       Date:  1991-06       Impact factor: 7.446

6.  Integrated system for the screening of the specificity of protein kinase inhibitors.

Authors:  J M Barret; A P Ernould; G Ferry; A Genton; J A Boutin
Journal:  Biochem Pharmacol       Date:  1993-08-03       Impact factor: 5.858

7.  Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.

Authors:  K B Reddy; G L Mangold; A K Tandon; T Yoneda; G R Mundy; A Zilberstein; C K Osborne
Journal:  Cancer Res       Date:  1992-07-01       Impact factor: 12.701

8.  Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors.

Authors:  A Gazit; P Yaish; C Gilon; A Levitzki
Journal:  J Med Chem       Date:  1989-10       Impact factor: 7.446

9.  Rapid uptake of tyrphostin into A431 human epidermoid cells is followed by delayed inhibition of epidermal growth factor (EGF)-stimulated EGF receptor tyrosine kinase activity.

Authors:  C A Faaland; F H Mermelstein; J Hayashi; J D Laskin
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

Review 10.  Molecular markers for the diagnosis and prognosis of lung cancer.

Authors:  A F Gazdar
Journal:  Cancer       Date:  1992-03-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.